David Brough
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
T-cell-targeted immunotherapy in neurofibromatosis type 2-related vestibular schwannoma: current evidence and future direction.
Journal: Brain communications
Published: November 24, 2025
Inflammatory responses following CRISPR modification of the nuclear localisation sequence in endogenous interleukin-1 alpha.
Journal: Disease models & mechanisms
Published: October 13, 2025
The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis.
Journal: Acta neuropathologica communications
Published: July 22, 2025
Skull-meninges-brain connectivity and extra-axial brain tumours.
Journal: Brain communications
Published: June 06, 2025
Dehydroisohispanolone alleviates NLRP3-driven inflammation in gout arthritis.
Journal: Biochemical pharmacology
Published: March 21, 2025
Selective deletion of interleukin-1 alpha in microglia does not modify acute outcome but may regulate neurorepair processes after experimental ischemic stroke.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: March 20, 2025
Digital interventions for supporting alcohol abstinence in aftercare - a systematic review.
Journal: Internet interventions
Published: February 25, 2025
Interleukin-1 regulates myeloid cell trafficking and cerebral blood flow following intracerebral haemorrhage.
Journal: Disease models & mechanisms
Published: January 28, 2025
Disruption of macrophage cell volume drives inflammatory responses and type I interferon signaling.
Journal: The Journal of cell biology
Published: November 19, 2024
Virtual screening-led design of inhibitor scaffolds for the NLRP3 inflammasome.
Journal: Bioorganic chemistry
Published: June 27, 2024
Last Updated: 09/26/2026